Newsroom

Argentum Medical Partners with sanaFactur for Distribution of Silverlon® Flex Wound Dressings in Germany

Posted by Argentum Medical

4/14/16 6:03 AM 0 Comments

Geneva, Ill. – Argentum Medical LLC, an industry-leading manufacturer of metallic silver-based, antimicrobial wound dressings, has reached an agreement with sanaFactur to be the exclusive distributor of Silverlon® Flex wound dressings in Germany. The two companies will be exhibiting together at the European Wound Management Association’s conference in Bremen, Germany, May 11-13, 2016 at booth 1 C 04.

Read More

Argentum Medical Awarded BARDA Contract

Posted by Argentum Medical

10/24/13 7:30 PM 0 Comments

Argentum Medical awarded BARDA contract valued up to $16.5 million, including options, if exercised, to repurpose Silverlon® burn and wound trauma dressings for use in mass casualty incidents involving radiation or chemical exposure.

GENEVA, IL (October 22, 2013) – Argentum Medical, an industry leading manufacturer of metallic silver based antimicrobial wound dressings, announced today that it has been awarded a contract by Biomedical Advanced Research and Development Authority (BARDA). Under this contract, Argentum Medical will conduct studies to evaluate the use of its Silverlon® brand burn and wound trauma dressings for potential use on patients affected by mass casualty incidents involving radiation or vesicant exposure.

BARDA supports the advanced research, development, and procurement of medical countermeasures against a variety of national security threats including, but not limited to, chemical, biological, radiological, and nuclear agents.

Read More

Argentum Medical Receives CE Mark for Silverlon® Antimicrobial Wound Dressings

Posted by Argentum Medical

8/26/13 7:52 PM 0 Comments

Argentum Medical, an industry leading manufacturer of antimicrobial barrier wound dressings, announced today that it has received Class III medicated wound dressing CE Mark approval for its Silverlon® wound dressings.  The CE mark designation will allow Silverlon dressings to be sold in the European Union and other countries requiring this approval.

“Receipt of the CE mark for Silverlon as a Class III medicated wound dressing is a significant accomplishment for Argentum Medical,” states Raul Brizuela, President and CEO.  “CE certification allows us to bring Silverlon’s technological benefits to healthcare facilities across Europe and other parts of the world.”

Read More

Investor Group Recapitilizes Silverlon® Manufacturer, Positions for Worldwide Growth of Technology

Posted by Argentum Medical

5/21/12 7:54 PM 0 Comments

Argentum Medical, manufacturer of Silverlon®,  announced today that it has completed a recapitalization and received a significant capital infusion by a group of investors led by Cura Surgical, the leading distributor of Silverlon products.

Since its inception in 2001, Argentum Medical, based in Chicago, IL, has sold millions of Silverlon antimicrobial silver barrier dressings, which include 65 different dressing combinations and sizes.

Read More

Argentum Medical LLC Announces New Patents and New Claims Allowed Covering Silveron® Antimicrobial Wound, Burn and Surgical Dressings

Posted by Argentum Medical

1/10/12 7:57 PM 0 Comments

Argentum Medical, LLC is very pleased to announce the issuance of US 7,989,674, US 8,093,444, and Allowed Claims for US Applications 11/930,541.  All cover Silverlon antimicrobial wound, burn and surgical dressings.  These patents not only clarify and expand patent protection to double layer fabrics, non-woven materials such as silver calcium alginates, but also include conductive gels.

Read More

Argentum Medical LLC Announces Patent Reexamination Result for Silverlon® Antimicrobial Wound, Burn and Surgical Dressings

Posted by Argentum Medical

10/31/11 8:00 PM 0 Comments

Argentum Medical, LLC is very pleased to announce the results of the second reexamination of its US 7,230,153 C1 patent for Silverlon antimicrobial wound, burn and surgical dressings.  Not only were original Claims 1-20 confirmed as amended, but newly filed Claims 21-40 were also found patentable.

Read More